|Vector Type||Mammalian Expression Vector|
|Expression Method||Constiutive ,Stable / Transient|
|Selection In Mammalian Cells||Hygromycin|
A myc tag is a polypeptide protein tag derived from the c-myc gene product that can be added to a protein using recombinant DNA technology. It can be used for affinity chromatography, then used to separate recombinant, overexpressed protein from wild type protein expressed by the host organism. It can also be used in the isolation of protein complexes with multiple subunits.
A myc tag can be used in many different assays that require recognition by an antibody. If there is no antibody against the studied protein, adding a myc-tag allows one to follow the protein with an antibody against the Myc epitope. Examples are cellular localization studies by immunofluorescence or detection by Western blotting.
The peptide sequence of the myc-tag is: N-EQKLISEEDL-C (1202 Da). It can be fused to the C-terminus and the N-terminus of a protein. It is advisable not to fuse the tag directly behind the signal peptide of a secretory protein, since it can interfere with translocation into the secretory pathway.
|Rhesus CD200 ORF mammalian expression plasmid, C-GFPSpark tag||CG90230-ACG|
|Rhesus CD200 ORF mammalian expression plasmid, C-OFPSpark / RFP tag||CG90230-ACR|
|Rhesus CD200 ORF mammalian expression plasmid, C-Flag tag||CG90230-CF|
|Rhesus CD200 ORF mammalian expression plasmid, C-His tag||CG90230-CH|
|Rhesus CD200 ORF mammalian expression plasmid, C-Myc tag||CG90230-CM|
|Rhesus CD200 ORF mammalian expression plasmid, C-HA tag||CG90230-CY|
|Rhesus CD200 Gene cDNA clone plasmid||CG90230-G|
|Rhesus CD200 ORF mammalian expression plasmid, N-Flag tag||CG90230-NF|
|Rhesus CD200 ORF mammalian expression plasmid, N-His tag||CG90230-NH|
|Rhesus CD200 ORF mammalian expression plasmid, N-Myc tag||CG90230-NM|
|Rhesus CD200 ORF mammalian expression plasmid, N-HA tag||CG90230-NY|
|Rhesus CD200 natural ORF mammalian expression plasmid||CG90230-UT|
|Learn more about expression Vectors|
CD200 (OX-2) is a cell surface glycoprotein that imparts immune privileges by suppressing alloimmune and autoimmune responses through its receptor, CD200R, expressed primarily on myeloid cells. Signals delivered through the CD200:CD200R axis have been shown to play an important role in the regulation of anti-tumor immunity, and overexpression of CD200 has been reported in a number of malignancies, including CLL, as well as on cancer stem cells. The role of CD200-CD200R signaling in immune regulation of the central nervous system has become a popular field of research in recent years. Many studies have shown that there is a close correlation between CD200-CD200R, microglia activation, and Parkinson's disease (PD). The ability of CD200 to suppress myeloid cell activation is critical for maintaining normal tissue homeostasis but may also enhance the survival of migratory neoplastic cells. CD200 and CD200R associate via their respective N-terminal Ig-like domains. CD200 has been characterized as an important immunoregulatory molecule, increased expression of which can lead to decreased transplant rejection, autoimmunity, and allergic disease. Elevated CD200 expression has been reported to be associated with poor prognosis in a number of human malignancies. In addition, CD200 also plays an important role in prevention of graft rejection, autoimmune diseases and spontaneous abortion.